Excavating from small samples is a challenging pharmacokinetic problem, where statistical methods can be applied. Pharmacokinetic data is special due to the small samples of high dimensionality, which makes it difficult to adopt conventional methods to predict the efficacy of traditional Chinese medicine (TCM) prescription. The main purpose of our study is to obtain some knowledge of the correlation in TCM prescription. Here, a novel method named Multi-target Regression Framework to deal with the problem of efficacy prediction is proposed. We employ the correlation between the values of different time sequences and add predictive targets of previous time as features to predict the value of current time. Several experiments are conducted to test the validity of our method and the results of leave-one-out cross-validation clearly manifest the competitiveness of our framework. Compared with linear regression, artificial neural networks, and partial least squares, support vector regression combined with our framework demonstrates the best performance, and appears to be more suitable for this task.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241636 | PMC |
http://dx.doi.org/10.1038/srep40652 | DOI Listing |
J Food Sci
December 2024
College of Computer and Information Engineering, Inner Mongolia Agricultural University, Hohhot, China.
As consumers increasingly prioritize food safety and nutritional value, the dairy industry faces a pressing need for rapid and accurate methods to detect essential nutritional components in milk, such as fat, protein, and lactose. Hyperspectral imaging (HSI) technology, known for its non-destructive, fast, and precise nature, shows great promise in food quality assessment. However, the high dimensionality of HSI data poses challenges for effective band selection and model optimization.
View Article and Find Full Text PDFJ Prim Care Community Health
December 2024
Exact Sciences Corporation, Madison, WI, USA.
Objectives: To describe member adherence to a mail-based, health insurer-sponsored gap closure program for colorectal cancer (CRC) screening using multi-target stool DNA (mt-sDNA; Cologuard) tests.
Methods: Combined patient data from Exact Sciences Laboratories LLC and data from mass-mailed mt-sDNA orders placed by a large Medicare Advantage Insurance Plan were analyzed (03/01/2023-06/30/2023). Adherence and time to test return were the primary and secondary outcomes, respectively.
Comput Biol Med
December 2024
Division of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University, Thailand. Electronic address:
Drug registration requires risk assessment of new active pharmaceutical ingredients or excipients to ensure they are safe for human health and the environment. However, traditional risk assessment is expensive and relies heavily on animal testing. Machine learning (ML) has been used as a risk assessment tool, providing less time, money, and involved animals than in vivo experiments.
View Article and Find Full Text PDFPhytomedicine
December 2024
The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, Gansu, PR China; Department of General Surgery, The Second Hospital of Lanzhou University & The Second Clinical Medical School, Lanzhou University, Lanzhou 730000, Gansu, China; Gansu Province Key Laboratory of Environmental Oncology, Lanzhou 730000, Gansu, PR China. Electronic address:
Background: M2-polarized tumor-associated macrophages (TAMs) predominate in tumor microenvironment (TME) and serve primary functions in tumor progression, including growth, angiogenesis, metastasis, immunosuppression, chemoresistance, and poor prognosis. The reversal of M2 polarization provides a new treatment strategy for cancer. Presently, the molecular mechanisms of M2 polarization have yet to be fully characterized, and there is a lack of effective therapeutic targets and drugs.
View Article and Find Full Text PDFPharmacogenomics
December 2024
Center for Translational Research, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China.
Background: Our objective was to explore the pharmacogenetic impact of three known functional variants in drug target genes and determine whether they can explain the inter-individual variation in therapeutic response.
Methods: In a post hoc analysis of data from randomized controlled clinical trials of chiglitazar, we genotyped 481 Chinese patients with T2DM and investigated the association of variants in PPAR genes with the therapeutic outcome separated by dose using linear regression.
Results: rs1800234, a gain-of-function variant of PPARA, had a dose-dependent pharmacogenetic impact on the therapeutic response to chiglitazar.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!